The Prevalence of Pulmonary Hypertension and the Significance of Different Biomarkers in Chronic Interstitial Lung Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Interstitial Lung Disease
- Sponsor
- University of Aarhus
- Enrollment
- 212
- Locations
- 2
- Status
- Completed
- Last Updated
- 13 years ago
Overview
Brief Summary
The presence of an abnormally increased pulmonary blood pressure worsens the prognosis of patients with interstitial pulmonary disease.
The aim of this study is to estimate the frequency of an increased blood pressure in the lungs among patient with interstitial pulmonary disease, and to evaluate the use of different biomarkers in diagnosis of the condition.
Detailed Description
The presence of increased pulmonary blood pressure is established by echocardiography and confirmed by right heart catheterization. The ability of NT-proBNP, vWf, troponin-t, D-dimer and exhaled NO to predict the presence of increased pressure in the pulmonary circulation is evaluated.
Investigators
Charlotte Andersen
MD
University of Aarhus
Eligibility Criteria
Inclusion Criteria
- •Interstitial pulmonary disease
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified